𝔖 Bobbio Scriptorium
✦   LIBER   ✦

VP-16 plus ifosfamide plus cisplatin (VIP) in refractory germ cell tumors

✍ Scribed by P. J. Loehrer; S. D. Williams; L. H. Einhorn

Book ID
112785353
Publisher
Springer-Verlag
Year
1986
Tongue
English
Weight
132 KB
Volume
111
Category
Article
ISSN
1432-1335

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Cisplatin plus VP-16 combination chemoth
Cisplatin plus VP-16 combination chemotherapy in advanced refractory breast cancer
✍ Dr. Fikri IΓ§li; Nazan GΓΌunel; Dilek DinΓ§lol; Handan KaraoΗ§uz; Ahmet Demirkazik πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 224 KB

Twenty-nine patients with advanced refractory breast cancer were treated with cisplatin 20 mg/m2/d and VP-16 100 mg/d for 5 days every 3 4 weeks. Ten patients received mitomycin C 10 mg/m2 every 6 weeks additionally. Partial response was obtained in 10 of 26 evaluable patients (38%). The response ra

The role of ifosfamide plus cisplatin-ba
The role of ifosfamide plus cisplatin-based chemotherapy as salvage therapy for patients with refractory germ cell tumors
✍ Robert J. Motzer; Karen Cooper; Nancy L. Geller; Dean F. Bajorin; Ethan Dmitrovs πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 537 KB

A prospective study of four cycles of etoposide with ifosfamide and cisplatin (VIP) chemotherapy was conducted in 42 germ cell tumor (GCT) patients who were refractory to cisplatin with etoposide/vinblastine-based therapy. Forty patients were evaluable for response. Ten patients (25%) had a complete